WHO Announces Approval of Indian COVID Vaccine Covovax

The World Health Organization (WHO) announced that it has certified the Indian COVID vaccine Covovax.

This vaccine “is produced by the Serum Institute of India under license from Novovax and is part of the Covax (international COVID-19 vaccine delivery system) portfolio, which will drive efforts to vaccinate more people in low-income countries”, Highlighted the WHO.

Vaccines remain one of the most effective methods of protection against severe forms and death caused by SARS-COV-2, despite the emergence of new variants”, Underlined the doctor Mariangela Simao, in charge of the access to medicines of the WHO.

This approval “It should facilitate access to vaccines for poor countries, 41 of which have not yet been able to vaccinate 10% of their population, while 98% of countries have not yet reached 40%”, He stressed.

WHO had set a goal of vaccinating 40% of the population in all countries by the end of the year.

This vaccine requires two doses and can be stored at temperatures of 2 ° to 8 ° Celsius, like commercial refrigerators have it.

.

You may also like

Immediate Access Pro